| 151 |
Serum profiles of extracellular matrix degradation inhibitors arcross the stages of liver fibrosis in chronic hepatitis C patients |
2014 |
| 152 |
Serum profiles of extracellular matrix degradation inhibitors arcross the stages of liver fibrosis in chronic hepatitis C patients |
2014 |
| 153 |
Serum profiles of extracellular matrix degradation inhibitors arcross the stages of liver fibrosis in chronic hepatitis C patients |
2014 |
| 154 |
Study of the impact of viral load of hepatitis C on patients with concomitant psoriasis vulgaris |
2014 |
| 155 |
Study of the impact of viral load of hepatitis C on patients with concomitant psoriasis vulgaris |
2014 |
| 156 |
Studying Echocardiographic changes and Carotid intima-media Thickness in Patients with Diabetic and non Diabetic fatty liver disease
|
2014 |
| 157 |
To treat or not to treat the" immunotolerant phase" of hepatitis B infection: A tunnel of controversy |
2014 |
| 158 |
Vitamin D and IL28B genotyping as predictors for Antiviral therapy: A retrospective study in Egyptian HCV genotype 4a |
2014 |
| 159 |
A revised scope in different prognostic models in cirrhotic patients: Current and future perspectives, an Egyptian experience |
2013 |
| 160 |
A revised scope in different prognostic models in cirrhotic patients: Current and future perspectives, an Egyptian experience |
2013 |